{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T13:24:33Z","timestamp":1785936273476,"version":"3.56.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T00:00:00Z","timestamp":1749945600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001794","name":"University of Queensland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014012","name":"Fight MND","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014012","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.bbi.2025.06.021","type":"journal-article","created":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T10:53:39Z","timestamp":1749898419000},"page":"296-304","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["IL-6 trans-signalling is elevated in ALS models and drives TDP-43 induced inflammatory responses in microglia"],"prefix":"10.1016","volume":"129","author":[{"given":"Grace","family":"Risby-Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianina","family":"Marallag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril Jones","family":"Jagaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie D.","family":"Atkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam K.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trent M.","family":"Woodruff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9976-7396","authenticated-orcid":false,"given":"John D.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny N.","family":"Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2025.06.021_b0005","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bbi.2013.01.002","article-title":"Central inhibition of interleukin-6 trans-signaling during peripheral infection reduced neuroinflammation and sickness in aged mice","volume":"30","author":"Burton","year":"2013","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2025.06.021_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120435","article-title":"Engineered extracellular vesicle decoy receptor-mediated modulation of the IL6 trans-signalling pathway in muscle","volume":"266","author":"Concei\u00e7\u00e3o","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbi.2025.06.021_b0015","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1136\/jnnp-2020-322983","article-title":"TDP-43 proteinopathies: a new wave of neurodegenerative diseases","volume":"92","author":"De Boer","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.bbi.2025.06.021_b0020","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/glia.23728","article-title":"The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins","volume":"68","author":"Deora","year":"2020","journal-title":"Glia"},{"key":"10.1016\/j.bbi.2025.06.021_b0025","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.bbi.2019.08.005","article-title":"IL-6 trans-signaling in the brain influences the behavioral and physio-pathological phenotype of the Tg2576 and 3xTgAD mouse models of Alzheimer\u2019s disease","volume":"82","author":"Escrig","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2025.06.021_b0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003444","article-title":"Functional IL6R 358Ala allele impairs classical IL-6 receptor signaling and influences risk of diverse inflammatory diseases","volume":"9","author":"Ferreira","year":"2013","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bbi.2025.06.021_b0035","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/sj.gene.6364120","article-title":"Polymorphisms in the IL-6 receptor (IL-6R) gene: strong evidence that serum levels of soluble IL-6R are genetically influenced","volume":"5","author":"Galicia","year":"2004","journal-title":"Genes & Immunity"},{"key":"10.1016\/j.bbi.2025.06.021_b0040","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1093\/bioinformatics\/btx657","article-title":"heatmaply: an R package for creating interactive cluster heatmaps for online publishing","volume":"34","author":"Galili","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bbi.2025.06.021_b0045","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1255533","article-title":"Interleukin 6: at the interface of human health and disease","volume":"14","author":"Grebenciucova","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbi.2025.06.021_b0050","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.637","article-title":"Evaluating the levels of CSF and serum factors in ALS","volume":"7","author":"Guo","year":"2017","journal-title":"Brain and Behavior"},{"key":"10.1016\/j.bbi.2025.06.021_b0055","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1126\/science.8209258","article-title":"Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation","volume":"264","author":"Gurney","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.bbi.2025.06.021_b0060","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1152\/japplphysiol.01026.2004","article-title":"IL-6-induced skeletal muscle atrophy","volume":"98","author":"Haddad","year":"2005","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.bbi.2025.06.021_b0065","article-title":"Interleukin-6 deficiency does not affect motor neuron disease caused by superoxide dismutase 1 mutation","volume":"11","author":"Han","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbi.2025.06.021_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-10-119","article-title":"Dysregulation of the complement cascade in the hSOD1 G93A transgenic mouse model of amyotrophic lateral sclerosis","volume":"10","author":"Lee","year":"2013","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbi.2025.06.021_b0075","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp.74.suppl_4.iv32","article-title":"The management of motor neurone disease","volume":"74","author":"Leigh","year":"2003","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.bbi.2025.06.021_b0080","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3389\/fimmu.2017.01005","article-title":"Role of neuroinflammation in amyotrophic lateral sclerosis: cellular mechanisms and therapeutic implications","volume":"8","author":"Liu","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbi.2025.06.021_b0085","first-page":"e244","article-title":"Systemic inflammatory response and neuromuscular involvement in amyotrophic lateral sclerosis","volume":"3","author":"Lu","year":"2016","journal-title":"Neurology: Neuroimmunology & Neuroinflammation"},{"key":"10.1016\/j.bbi.2025.06.021_b0090","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci15010084","article-title":"Enhanced interleukin 6 trans-signaling modulates disease process in amyotrophic lateral sclerosis mouse models","volume":"15","author":"Milligan","year":"2025","journal-title":"Brain Sci."},{"key":"10.1016\/j.bbi.2025.06.021_b0095","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.3390\/ijms20112759","article-title":"Are circulating cytokines reliable biomarkers for amyotrophic lateral sclerosis?","volume":"20","author":"Moreno-Martinez","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbi.2025.06.021_b0100","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00801","article-title":"Circulating cytokines could not be good prognostic biomarkers in a mouse model of amyotrophic lateral sclerosis","volume":"10","author":"Moreno-Mart\u00ednez","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbi.2025.06.021_b0105","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.bbi.2025.06.021_b0110","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.chest.2018.06.035","article-title":"Respiratory failure in amyotrophic lateral sclerosis","volume":"155","author":"Niedermeyer","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.bbi.2025.06.021_b0115","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1038\/s41598-017-02088-2","article-title":"Cancer cachexia associates with a systemic autophagy-inducing activity mimicked by cancer cell-derived IL-6 trans-signaling","volume":"7","author":"Pettersen","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbi.2025.06.021_b0120","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jns.2019.01.026","article-title":"Interleukin-6 and amyotrophic lateral sclerosis","volume":"398","author":"Pronto-Laborinho","year":"2019","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbi.2025.06.021_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2022.101747","article-title":"A robust approach to differentiate human monocyte-derived microglia from peripheral blood mononuclear cells","volume":"3","author":"Quek","year":"2022","journal-title":"STAR Protoc."},{"key":"10.1016\/j.bbi.2025.06.021_b0130","doi-asserted-by":"crossref","unstructured":"Quillen, D., Hughes, T.M., Craft, S., Howard, T., Register, T., Suerken, C., Hawkins, G.A., Milligan, C., 2023. Levels of soluble interleukin 6 receptor and Asp358Ala are associated with cognitive performance and alzheimer disease biomarkers. Neurol Neuroimmunol Neuroinflamm 10.","DOI":"10.1212\/NXI.0000000000200095"},{"key":"10.1016\/j.bbi.2025.06.021_b0135","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1600-0404.2010.01333.x","article-title":"Interleukin\u201017 and interleukin\u201023 are elevated in serum and cerebrospinal fluid of patients with ALS: a reflection of Th17 cells activation?","volume":"122","author":"Rentzos","year":"2010","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.bbi.2025.06.021_b0140","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1343503","article-title":"Bystander activation of microglia by Brucella abortus-infected astrocytes induces neuronal death via IL-6 trans-signaling","volume":"14","author":"Rodr\u00edguez","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbi.2025.06.021_b0145","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.7150\/ijbs.4989","article-title":"IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6","volume":"8","author":"Rose-John","year":"2012","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbi.2025.06.021_b0150","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41577-023-00856-y","article-title":"Targeting IL-6 trans-signalling: past, present and future prospects","volume":"23","author":"Rose-John","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbi.2025.06.021_b0155","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/362059a0","article-title":"Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis","volume":"362","author":"Rosen","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.bbi.2025.06.021_b0160","doi-asserted-by":"crossref","unstructured":"Rothaug, M., Becker-Pauly, C., Rose-John, S., 2016. The role of interleukin-6 signaling in nervous tissue. Biochimica et Biophysica Acta (BBA)-Mol. Cell Res. 1863, 1218-1227.","DOI":"10.1016\/j.bbamcr.2016.03.018"},{"key":"10.1016\/j.bbi.2025.06.021_b0165","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.bbamcr.2011.01.034","article-title":"The pro-and anti-inflammatory properties of the cytokine interleukin-6","volume":"1813","author":"Scheller","year":"2011","journal-title":"Biochimica et Biophysica Acta (BBA)-Mol. Cell Res."},{"key":"10.1016\/j.bbi.2025.06.021_b0170","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.2174\/092986707780597961","article-title":"Microglial activation and its implications in the brain diseases","volume":"14","author":"Thameem Dheen","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbi.2025.06.021_b0175","first-page":"1185","article-title":"ALS and other motor neuron diseases. CONTINUUM: lifelong learning","volume":"20","author":"Tiryaki","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.bbi.2025.06.021_b0180","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00401-015-1460-x","article-title":"Functional recovery in new mouse models of ALS\/FTLD after clearance of pathological cytoplasmic TDP-43","volume":"130","author":"Walker","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbi.2025.06.021_b0185","doi-asserted-by":"crossref","first-page":"16975","DOI":"10.1073\/pnas.1315862110","article-title":"STAT3 activation in response to IL-6 is prolonged by the binding of IL-6 receptor to EGF receptor","volume":"110","author":"Wang","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"833\u2013846","key":"10.1016\/j.bbi.2025.06.021_b0190","first-page":"e816","article-title":"Repopulating microglia promote brain repair in an IL-6-dependent manner","volume":"180","author":"Willis","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.bbi.2025.06.021_b0195","first-page":"e2422","article-title":"Extraction of soluble and insoluble protein fractions from mouse brains and spinal cords","volume":"7","author":"Wirths","year":"2017","journal-title":"Bio-Protocol"},{"key":"10.1016\/j.bbi.2025.06.021_b0200","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/21678421.2020.1813310","article-title":"Interleukin 6 (IL6) level is a biomarker for functional disease progression within IL6R358Ala variant groups in amyotrophic lateral sclerosis patients","volume":"22","author":"Wosiski-Kuhn","year":"2021","journal-title":"Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration"},{"key":"10.1016\/j.bbi.2025.06.021_b0205","first-page":"e631","article-title":"IL6 receptor358Ala variant and trans-signaling are disease modifiers in amyotrophic lateral sclerosis","volume":"6","author":"Wosiski-Kuhn","year":"2019","journal-title":"Neurology: Neuroimmunology & Neuroinflammation"},{"key":"10.1016\/j.bbi.2025.06.021_b0210","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.638983","article-title":"The role of autophagy in skeletal muscle diseases","volume":"12","author":"Xia","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bbi.2025.06.021_b0215","doi-asserted-by":"crossref","first-page":"32297","DOI":"10.18632\/oncotarget.6027","article-title":"IL-11 in multiple sclerosis","volume":"6","author":"Zhang","year":"2015","journal-title":"Oncotarget"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159125002387?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159125002387?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T20:49:29Z","timestamp":1759610969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159125002387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":43,"alternative-id":["S0889159125002387"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2025.06.021","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-6 trans-signalling is elevated in ALS models and drives TDP-43 induced inflammatory responses in microglia","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2025.06.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}